Clinical Trials Browser

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02608216 2025-09-03

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Phase 1 Active not recruiting

20 enrolled

Breast

Breast Neoplasms

NCT00880074 2023-06-26

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Phase 1 Completed

10 enrolled

Tumor-Agnostic

Neoplasms

NCT00813566 2022-04-27

Multi-Tracer PET Assessment of Primary Brain Tumors

Phase 1 Completed

11 enrolled

CNS

Brain Neoplasms, Neoplasms

NCT00633958 2021-10-20

FLT

Phase 1 Terminated

2 enrolled

CNS

Disease, Central Nervous System Neoplasms

NCT02146222 2019-11-18

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

Phase 1 Completed

14 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02891616 2019-07-17

18F-FLT PET Imaging in Patients With Advanced Melanoma

Phase 1 Terminated

4 enrolled

Dermatologic

Melanoma

NCT01480050 2019-05-22

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Phase 1 Completed

28 enrolled

CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00575393 2018-10-09

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

17 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00499135 2017-10-10

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT01283178 2016-10-31

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Phase 1 Terminated

3 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms

NCT01243359 2014-04-02

Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

Phase 1 Completed

6 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00070239 2013-12-16

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Phase 1 Terminated

100 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00553748 2008-07-03

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Phase 1 Completed

11 enrolled

CNS

Brain Neoplasms

Clinical Trials

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Multi-Tracer PET Assessment of Primary Brain Tumors

FLT

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

18F-FLT PET Imaging in Patients With Advanced Melanoma

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Phase I, Open Label, Single Center Safety Study of [F-18]FLT